WELL Health Reports HEALWELL AI and WELLSTAR Subsidiaries Are Selected for Canada Health Infoway’s Vendor Innovation Program
-
WELL Health is pleased to report that HEALWELL’s wholly owned subsidiary Intrahealth, non-wholly owned subsidiary Pentavere along with WELLSTAR’s subsidiary OceanMD have been selected by Canada Health Infoway as recipients for the 2025 Vendor Innovation Program. The Vendor Innovation Program is designed to accelerate the development, clinical implementation and adoption of interoperability in healthcare settings across
Canada . -
Intrahealth, Pentavere and OceanMD are engaging in projects that accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians across
Canada . Their projects were selected not only based on technical merit, but for their demonstrated potential to deliver real, lasting impact on Canada’s digital health priorities. -
Three out of the eight winners of the Vendor Innovation Program are from the WELL Health and HEALWELL families. This achievement highlights the group’s leadership and innovation in the digital health sector, further solidifying its role in transforming healthcare in
Canada .
Infoway’s Vendor Innovation Program (VIP) is designed to accelerate the development and clinical implementation of real-world interoperability innovations that are aligned with the Shared Pan-Canadian Interoperability Roadmap. The program empowers selected vendors to develop and implement innovations that accelerate the adoption of interoperability. This year’s winning projects exemplify how innovation can accelerate the adoption of interoperability by improving data quality, enhancing care coordination, and expanding access to standardized, actionable health information for patients and clinicians.
“The Vendor Innovation Program is a critical component in mobilizing Canada’s digital health industry,” says Abhi Kalra, Executive Vice President, Connected Care at Canada Health Infoway. “By supporting the implementation of real-world solutions in clinical settings, we are helping to demonstrate what’s possible when innovation is aligned with national priorities and focused on the needs of patients and care teams.”
Dr. Alexander Dobranowski, CEO of HEALWELL, said, “Intrahealth and Pentavere’s recognition through the Vendor Innovation Program demonstrates the tremendous impact HEALWELL companies are having in the digital health landscape. Both companies are at the forefront of transforming healthcare delivery with innovative solutions that enhance data-driven care coordination, streamline workflows, and empower clinicians to deliver better patient outcomes. We remain committed to improving patient care and supporting healthcare providers with actionable insights, while also focusing on addressing the needs of underserved and rural communities, where our technology can make the most meaningful difference.”
Amir Javidan, CEO of WELLSTAR, said, “We are incredibly proud to see OceanMD, as part of WELLSTAR, recognized for its innovation in improving healthcare outcomes through digital technologies. This recognition is a testament to the exceptional work our team is doing in transforming patient care, and we are excited to see the impact this will have in clinical settings across
Selected from more than 40 applications across the country, the 2025 VIP cohort reflects the breadth of Canada’s healthcare landscape, including solutions targeting primary care, acute care, and Indigenous and rural communities. The three recipient projects from the WELL Health family are as follows:
- Pentavere: Integrating its DARWEN™ AI system with EMRs to generate clinician-facing patient summaries, reducing chart review time and improving provider efficiency.
- OceanMD: Enhancing its eReferral system with open APIs and AI automation to streamline referral workflows and support real-time clinical decision-making.
-
Intrahealth: Developing standardized FHIR-based tools to enable seamless, accurate transfer of full patient records between EMR systems across
Canada .
These projects were selected not only for their technical merit, but for their demonstrated potential to deliver real, lasting impact on Canada’s digital health priorities. These three initiatives will be deployed in live clinical environments, across
WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
WELL Health Technologies Inc.
About WELL Health Technologies Corp.
WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 42,000 healthcare providers between the US and
About Canada Health Infoway
Canada Health Infoway (Infoway) is an independent, not-for-profit organization funded by the federal government and accountable to its Board of Directors and Members of the Corporation (Canada’s 14 federal, provincial and territorial deputy ministers of health). Infoway is led by a team of seasoned professionals who are specialists in their respective fields, including health care, administration, information technology and privacy. Learn more online at www.infoway-inforoute.ca.
Forward Looking Statements
Certain statements in this press release, constitute "forward-looking information" and "forward looking statements" (collectively, "forward looking statements") within the meaning of applicable Canadian securities laws, including the Company’s, WELLSTAR’s, and HEALWELL’s plan to further develop and deploy technologies in clinical environments. Forward-looking statements are often, but not always, identified by words or phrases such as "building”, “scaling”, “to become”, “opportunity”, “burgeoning”, “continue to”, “focus”, “believe”, “pursue”, “entering”, “growth”, “expect”, “intend”, “anticipate” or variations of such words and phrases or statements that certain future conditions, actions, events or results "will", "may", "could", "would", "should", "might" or "can" be taken, occur or be achieved, or the negative of any of these terms. Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by the Company, HEALWELL, and WELLSTAR as of the date of such statements, are outside of their control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to: WELL’s, HEALWELL’s and WELLSTAR’s ability to further develop the technologies identified above, and identifying customers interested in deploying such technologies in a clinical environment; the continued adoption of the software, tools and solutions created by WELL, WELLSTAR and HEALWELL; sufficiency of working capital and access to financing; WELL’s, WELLSTAR’s and HEALWELL’s ability to comply with applicable laws and regulations; technologies working as intended or at all; trends in customer growth and the adoption of new technologies in the industry; and that the risk factors noted below, collectively, do not have a material impact on HEALWELL's business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections, or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.
Known and unknown risk factors, many of which are beyond the control of WELL and HEALWELL, could cause the actual results of WELL and HEALWELL to differ materially from the results, performance, achievements, or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled "Risk Factors" in WELL’s most recent annual information form dated April 15, 2025, which is available under WELL’s SEDAR+ profile, and HEALWELL's most recent annual information form dated March 31, 2025, which is available under HEALWELL's SEDAR+ profile. The risk factors are not intended to represent a complete list of the factors that could affect WELL and HEALWELL and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. WELL and HEALWELL disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250528419380/en/
For more information:
Tyler Baba
Investor Relations, Manager
604-628-7266
investor@well.company
Source: WELL Health Technologies Corp.
